- About Welchol
- LDL-C and A1C Reductions
- Register For Updates
Welchol® (colesevelam HCl) is the only therapy suggested by the AACE† in 2013 as an
add-on to a statin and metformin to lower LDL-C and A1C.1
†AACE=American Association of Clinical Endocrinologists.
The photos depict models, not actual patients or healthcare professionals.
You are leaving WelcholHCP.com
Please Note: You are about to leave the WelcholHCP.com website by opening a new page. Daiichi Sankyo, Inc. does not control the content of the website connected to this link.cancel continue